Disease management system and method including medication therapy self-management
View Patent ↗A method and system for patient medication therapy self-management. The system performs medication therapy self-management in a fully automated manner, using periodic interactive dialogs with a patient to obtain health state measurements from the patient. The system and method utilizes a computer usable medium having computer readable program code embodied therein for representing a description of a pain in a digitized form allowing the patient to directly interact with the program code via the periodic dialogs. The system and method utilizes a therapy alteration permission level (TAPL) limiting the possible self-adjustments available to the patient to change the patient's therapy. Via the interactive dialogs, the patient self-selects aspect words concerning the patient's current pain allowing the program code to adjust the patient's medication therapy within the TAPL.
1. A patient medication therapy self-management method, utilizing a non-transitory computer readable medium, operating a computer readable program code, configured to provide therapy according to patient self-assessed pain, the computer readable code comprising instructions that are executed by a computer device or processor, causing the processor to perform the steps of:
storing, in a data storage accessible to the program code,
(a) a listing of aspect words describing a pain and at least one of a degree or description of the pain; and
(b) a therapy alteration permission level (TAPL) limiting available therapy changes;
receiving, via direct interactive dialog between the patient and the computer device or processor, a patient self-selection of an aspect word from the listing of aspect words, the self-selection describing a pain experienced by the patient, the computer device or processor providing an interface configured to engage the patient in the direct interactive dialog;
converting the received aspect word into an integer subcode that represents the received aspect word; and
altering the patient's therapy within the limitations of the TAPL based on at least one of the integer subcodes.
2. The method of claim 1 , wherein the listing of aspect words further includes at least one of provocative, quality, region, severity, and timing.
3. The method of claim 1 , wherein the TAPL further includes a limitation applicable to at least one of: a maximum and minimum dosage change associated with a current therapy of the patient, a drug class, a drug type, a drug brand, a dose, a route, a mode of drug administration, a formulation, a timing, and a frequency.
4. The method of claim 1 , wherein the available therapy changes further include at least one of: an increased dosage, a decreased dosage, a new treatment, a drug class, a drug type, a drug brand, a dose, a route, a mode of drug administration, a formulation, a timing, and a frequency.
5. The method of claim 1 , wherein the integer subcode that represents the received aspect word further identifies at least one of location, sensation, or frequency.
6. The method of claim 1 , wherein the medication therapy self-management further includes therapy changes based on a subjective patient description of pain factored by a subjective objective correlation factor (SOCF).
7. The method of claim 4 , wherein the available therapy changes further include an increase or decrease of dosage in conformance with a treatment table factored by a subjective objective correlation factor (SOCF).
8. The method of claim 4 , wherein the new treatment further includes an additional or substitute therapy type.
9. A system for patient medication therapy self-management, the system comprising:
a computer readable medium having non-transitory computer readable program code embodied therein for providing therapy according to patient self-assessed pain, the computer readable program code executed by a computer device or processor;
a data storage accessible to the program code, the data storage configured to store;
(a) a listing of aspect words describing a pain and at least one of a degree or description of the pain;
(b) a therapy alteration permission level (TAPL) limiting available therapy changes;
(c) a patient self-selection of an aspect word from the listing of aspect words, the self-selection received via direct interactive dialog between the patient and the computer device or processor, the computer device or processor providing an interface configured to engage the patient in the direct interactive dialog, the self-selection describing a pain experienced by the patient; and
(d) a conversion of the received patient self-selection of an aspect word into an integer subcode, the subcode representing the received aspect word;
wherein the computer device or processor alters the patient's therapy within the limitations of the TAPL based on at least one of the integer subcodes.
10. The system of claim 9 , wherein the listing of aspect words further includes at least one of provocative, quality, region, severity, and timing.
11. The system of claim 9 , wherein the TAPL further includes a limitation applicable to at least one of: a maximum and minimum dosage change associated with a current therapy of the patient, a drug class, a drug type, a drug brand, a dose, a route, a mode of drug administration, a formulation, a timing, and a frequency.
12. The system of claim 9 , wherein the available therapy changes further include at least one of: an increased dosage, a decreased dosage, a new treatment, a drug class, a drug type, a drug brand, a dose, a route, a mode of drug administration, a formulation, a timing, and a frequency.
13. The system of claim 9 , wherein the integer subcode that represents the received aspect word further identifies at least one of location, sensation, or frequency.
14. The system of claim 9 , wherein the medication therapy self-management further includes therapy changes based on a subjective patient description of pain factored by a subjective objective correlation factor (SOCF).
15. The system of claim 12 , wherein the available therapy changes further include an increase or decrease of dosage in conformance with a treatment table factored by a subjective objective correlation factor (SOCF).
16. The system of claim 12 , wherein the new treatment further includes an additional or substitute therapy type.